Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
Harpoon Therapeutics Total Liabilities (Quarterly): 43.04M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 43.04M |
June 30, 2023 | 60.20M |
March 31, 2023 | 80.09M |
December 31, 2022 | 68.33M |
September 30, 2022 | 66.58M |
June 30, 2022 | 82.31M |
March 31, 2022 | 91.06M |
December 31, 2021 | 97.38M |
September 30, 2021 | 97.70M |
June 30, 2021 | 105.25M |
March 31, 2021 | 158.94M |
Date | Value |
---|---|
December 31, 2020 | 117.75M |
September 30, 2020 | 122.58M |
June 30, 2020 | 125.22M |
March 31, 2020 | 79.20M |
December 31, 2019 | 82.38M |
September 30, 2019 | 35.16M |
June 30, 2019 | 34.54M |
March 31, 2019 | 33.34M |
December 31, 2018 | 156.06M |
September 30, 2018 | 76.29M |
December 31, 2017 | 58.82M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
43.04M
Minimum
Sep 2023
158.94M
Maximum
Mar 2021
92.38M
Average
86.72M
Median
Total Liabilities (Quarterly) Benchmarks
Merck & Co Inc | 72.97B |
Axonics Inc | 109.68M |
Johnson & Johnson | 108.13B |
Boston Scientific Corp | 17.12B |
Ambrx Biopharma Inc (DELISTED) | 29.10M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 47.58M |
Shareholders Equity (Quarterly) | 4.541M |
Current Ratio | 1.894 |